Case Assignment: Brand Name Prescription Drugs Economics 33
For class discussion Friday, May 14th Prof. Stephen Schmidt
Read the case “The Brand Name Prescription Drugs Antitrust
Litigation” in Antitrust Revolution (pages 301-320). Provide a typed one
or two page answer to the following question (the graphs can be hand-drawn):
Draw the demand curve for prescription drugs by retail
pharmacies, and also the demand curve for prescription drugs by managed care
organizations. (I will call someone to the board to do this in discussion.) How
do these curves justify a higher price for retail pharmacies?
Be prepared to discuss that question and the following questions in class. Also
prepare two questions of your own regarding the case to ask in class discussion.
Make sure you understand the definitions of “chargebacks”, “rebates”, and
“formulary” for discussion. They are all defined early in the case, and parts
of the rest of the case is more difficult to understand if you do not make note
of what these are (especially the last).
1.
Exactly what are pharmaceutical firms being accused of doing?
Is it price fixing or something else? Is it a unilateral practice or a
multilateral practice? If they are being accused of doing more than one thing,
answer the latter two questions for each. What has been settled by litigation
thus far, and what remains to be settled?
2.
What does the case mean when it says that retail pharmacies do
not have the ability to “move market share”? Why does it think that hospitals
and managed care organizations do have that ability? What evidence was
presented about the ability of pharmacies to do so, and what view of the case
did that evidence support?
3.
How did the defendants justify charging different prices for
identical drugs to different customers? They had more than one justification –
which of these justifications seem like acceptable ones to you (either from an
economic standpoint or another standpoint) and which are problematic for you?
Why do you think so?
4.
The current law on price discrimination is Section 2 of the
Clayton Act as amended by the Robinson-Patman Act. It is linked on the class
website. Read the first paragraph of the law (read the rest too, but the first
paragraph is the most important portion). Based on that, plus the information
in this case, do you think the defendants will win or lose when (if) the price
discrimination charges are heard? What evidence makes you think so?
5. What is the difference between the efficiency philosophy of antitrust and the populist philosophy of antitrust? Pick one other case we have read and explain what the populist philosophy of antitrust would think of that case, and why it would think so.